Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
16
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Lu Hongbo | Director | 4 | $0 | $0 | 2019-11-21 |
| Rajpal Rajesh K. | Chief Medical Officer | 47 | $0 | $0 | 2019-11-21 |
| First David | Chief Human Resources Officer | 9 | $21.0K | $0 | 2019-11-21 |
| Zadno Reza | President and CEO | 21 | $0 | $0 | 2019-11-21 |
| GRIFFIN THOMAS E | Chief Financial Officer | 13 | $21.0K | $0 | 2019-11-21 |
| Bavier Paul S | General Counsel and Sec. | 12 | $0 | $0 | 2019-11-21 |
| INTERWEST PARTNERS X LP | 10% Owner | 2 | $0 | $0 | 2019-11-21 |
| Kong Garheng | Director | 12 | $2.00M | $0 | 2019-11-21 |
| Schuermann James | Chief Business Officer | 8 | $0 | $0 | 2019-11-21 |
| Zurbay Donald | Director | 8 | $49.0K | $0 | 2019-11-21 |
| SILVERSTEIN JONATHAN | Director, 10% Owner | 11 | $0 | $0 | 2019-11-21 |
| PALMISANO ROBERT J | Director | 15 | $0 | $0 | 2019-11-21 |
| Burns Thomas William | Director | 2 | $0 | $0 | 2019-06-14 |
| Kliman Gilbert H | Director, 10% Owner | 9 | $350.0K | $0 | 2019-06-14 |
| OrbiMed Capital GP VI LLC | 10% Owner | 6 | $0 | $0 | 2019-02-19 |
| NASR KHALED | 10% Owner | 6 | $0 | $0 | 2019-02-19 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Bavier Paul S | General Counsel and Sec. | D To issuer deriv | 2019-11-21 | 2019-11-25 | 8,988 | — | $0 | 0 | SEC↗ |
| Bavier Paul S | General Counsel and Sec. | D To issuer deriv | 2019-11-21 | 2019-11-25 | 5,452 | — | $0 | 0 | SEC↗ |
| Bavier Paul S | General Counsel and Sec. | D To issuer deriv | 2019-11-21 | 2019-11-25 | 4,719 | — | $0 | 0 | SEC↗ |
| Bavier Paul S | General Counsel and Sec. | D To issuer deriv | 2019-11-21 | 2019-11-25 | 12,717 | — | $0 | 0 | SEC↗ |
| Bavier Paul S | General Counsel and Sec. | D To issuer deriv | 2019-11-21 | 2019-11-25 | 44,494 | — | $0 | 0 | SEC↗ |
| Bavier Paul S | General Counsel and Sec. | D To issuer deriv | 2019-11-21 | 2019-11-25 | 84,494 | — | $0 | 0 | SEC↗ |
| First David | Chief Human Resources Office | D To issuer deriv | 2019-11-21 | 2019-11-25 | 56,179 | — | $0 | 0 | SEC↗ |
| First David | Chief Human Resources Office | D To issuer deriv | 2019-11-21 | 2019-11-25 | 39,550 | — | $0 | 0 | SEC↗ |
| First David | Chief Human Resources Office | D To issuer deriv | 2019-11-21 | 2019-11-25 | 11,304 | — | $0 | 0 | SEC↗ |
| GRIFFIN THOMAS E | Chief Financial Officer | D To issuer deriv | 2019-11-21 | 2019-11-25 | 15,093 | — | $0 | 0 | SEC↗ |
| GRIFFIN THOMAS E | Chief Financial Officer | D To issuer deriv | 2019-11-21 | 2019-11-25 | 22,921 | — | $0 | 0 | SEC↗ |
| GRIFFIN THOMAS E | Chief Financial Officer | D To issuer deriv | 2019-11-21 | 2019-11-25 | 6,093 | — | $0 | 0 | SEC↗ |
| GRIFFIN THOMAS E | Chief Financial Officer | D To issuer deriv | 2019-11-21 | 2019-11-25 | 109,832 | — | $0 | 0 | SEC↗ |
| GRIFFIN THOMAS E | Chief Financial Officer | D To issuer deriv | 2019-11-21 | 2019-11-25 | 52,808 | — | $0 | 0 | SEC↗ |
| Lu Hongbo | Director | D To issuer deriv | 2019-11-21 | 2019-11-25 | 3,005 | — | $0 | 0 | SEC↗ |
| Lu Hongbo | Director | D To issuer deriv | 2019-11-21 | 2019-11-25 | 8,314 | — | $0 | 0 | SEC↗ |
| PALMISANO ROBERT J | Director | D To issuer deriv | 2019-11-21 | 2019-11-25 | 12,628 | — | $0 | 0 | SEC↗ |
| PALMISANO ROBERT J | Director | D To issuer deriv | 2019-11-21 | 2019-11-25 | 10,224 | — | $0 | 0 | SEC↗ |
| PALMISANO ROBERT J | Director | D To issuer deriv | 2019-11-21 | 2019-11-25 | 8,314 | — | $0 | 0 | SEC↗ |
| PALMISANO ROBERT J | Director | D To issuer deriv | 2019-11-21 | 2019-11-25 | 28,089 | — | $0 | 0 | SEC↗ |
| PALMISANO ROBERT J | Director | D To issuer deriv | 2019-11-21 | 2019-11-25 | 1,081 | — | $0 | 0 | SEC↗ |
| PALMISANO ROBERT J | Director | D To issuer deriv | 2019-11-21 | 2019-11-25 | 3,005 | — | $0 | 0 | SEC↗ |
| Rajpal Rajesh K. | Chief Medical Officer | D To issuer deriv | 2019-11-21 | 2019-11-25 | 20,371 | — | $0 | 0 | SEC↗ |
| Rajpal Rajesh K. | Chief Medical Officer | D To issuer deriv | 2019-11-21 | 2019-11-25 | 4,222 | — | $0 | 0 | SEC↗ |
| Rajpal Rajesh K. | Chief Medical Officer | D To issuer deriv | 2019-11-21 | 2019-11-25 | 14,016 | — | $0 | 0 | SEC↗ |
| Rajpal Rajesh K. | Chief Medical Officer | D To issuer deriv | 2019-11-21 | 2019-11-25 | 5,535 | — | $0 | 0 | SEC↗ |
| Rajpal Rajesh K. | Chief Medical Officer | D To issuer deriv | 2019-11-21 | 2019-11-25 | 70 | — | $0 | 0 | SEC↗ |
| Rajpal Rajesh K. | Chief Medical Officer | D To issuer deriv | 2019-11-21 | 2019-11-25 | 141 | — | $0 | 0 | SEC↗ |
| Rajpal Rajesh K. | Chief Medical Officer | D To issuer deriv | 2019-11-21 | 2019-11-25 | 44,494 | — | $0 | 0 | SEC↗ |
| Rajpal Rajesh K. | Chief Medical Officer | D To issuer deriv | 2019-11-21 | 2019-11-25 | 14,130 | — | $0 | 0 | SEC↗ |
| Rajpal Rajesh K. | Chief Medical Officer | D To issuer deriv | 2019-11-21 | 2019-11-25 | 212 | — | $0 | 0 | SEC↗ |
| Schuermann James | Chief Business Officer | D To issuer deriv | 2019-11-21 | 2019-11-25 | 148,699 | — | $0 | 0 | SEC↗ |
| Schuermann James | Chief Business Officer | D To issuer deriv | 2019-11-21 | 2019-11-25 | 14,130 | — | $0 | 0 | SEC↗ |
| Schuermann James | Chief Business Officer | D To issuer deriv | 2019-11-21 | 2019-11-25 | 49,438 | — | $0 | 0 | SEC↗ |
| SILVERSTEIN JONATHAN | Director, 10% Owner | D To issuer deriv | 2019-11-21 | 2019-11-25 | 3,005 | — | $0 | 0 | SEC↗ |
| SILVERSTEIN JONATHAN | Director, 10% Owner | D To issuer deriv | 2019-11-21 | 2019-11-25 | 8,314 | — | $0 | 0 | SEC↗ |
| Zadno Reza | President and CEO | D To issuer deriv | 2019-11-21 | 2019-11-25 | 267,415 | — | $0 | 0 | SEC↗ |
| Zadno Reza | President and CEO | D To issuer deriv | 2019-11-21 | 2019-11-25 | 525,682 | — | $0 | 0 | SEC↗ |
| Zadno Reza | President and CEO | D To issuer deriv | 2019-11-21 | 2019-11-25 | 200,820 | — | $0 | 0 | SEC↗ |
| Zadno Reza | President and CEO | D To issuer deriv | 2019-11-21 | 2019-11-25 | 2,103 | — | $0 | 0 | SEC↗ |
| Zadno Reza | President and CEO | D To issuer deriv | 2019-11-21 | 2019-11-25 | 76,430 | — | $0 | 0 | SEC↗ |
| Zurbay Donald | Director | D To issuer deriv | 2019-11-21 | 2019-11-25 | 3,005 | — | $0 | 0 | SEC↗ |
| Zurbay Donald | Director | D To issuer deriv | 2019-11-21 | 2019-11-25 | 10,224 | — | $0 | 0 | SEC↗ |
| Zurbay Donald | Director | D To issuer deriv | 2019-11-21 | 2019-11-25 | 8,314 | — | $0 | 0 | SEC↗ |
| Zurbay Donald | Director | D To issuer deriv | 2019-11-21 | 2019-11-25 | 41,941 | — | $0 | 0 | SEC↗ |
| Kong Garheng | Director | D To issuer deriv | 2019-11-21 | 2019-11-26 | 3,005 | — | $0 | 0 | SEC↗ |
| Kong Garheng | Director | D To issuer deriv | 2019-11-21 | 2019-11-26 | 8,314 | — | $0 | 0 | SEC↗ |
| Bavier Paul S | General Counsel and Sec. | D To issuer | 2019-11-21 | 2019-11-25 | 606 | — | $0 | 0 | SEC↗ |
| First David | Chief Human Resources Office | D To issuer | 2019-11-21 | 2019-11-25 | 2,254 | — | $0 | 0 | SEC↗ |
| GRIFFIN THOMAS E | Chief Financial Officer | D To issuer | 2019-11-21 | 2019-11-25 | 12,507 | — | $0 | 0 | SEC↗ |
| PALMISANO ROBERT J | Director | D To issuer | 2019-11-21 | 2019-11-25 | 37,733 | — | $0 | 0 | SEC↗ |
| Rajpal Rajesh K. | Chief Medical Officer | D To issuer | 2019-11-21 | 2019-11-25 | 127,666 | — | $0 | 0 | SEC↗ |
| Schuermann James | Chief Business Officer | D To issuer | 2019-11-21 | 2019-11-25 | 942 | — | $0 | 0 | SEC↗ |
| SILVERSTEIN JONATHAN | Director, 10% Owner | D To issuer | 2019-11-21 | 2019-11-25 | 4,240,128 | — | $0 | 0 | SEC↗ |
| Zadno Reza | President and CEO | D To issuer | 2019-11-21 | 2019-11-25 | 18,062 | — | $0 | 0 | SEC↗ |
| Zadno Reza | President and CEO | D To issuer | 2019-11-21 | 2019-11-25 | 315 | — | $0 | 0 | SEC↗ |
| Zurbay Donald | Director | D To issuer | 2019-11-21 | 2019-11-25 | 3,500 | — | $0 | 0 | SEC↗ |
| INTERWEST PARTNERS X LP | 10% Owner | U Tender | 2019-11-21 | 2019-11-25 | 3,005 | — | $0 | 0 | SEC↗ |
| INTERWEST PARTNERS X LP | 10% Owner | U Tender | 2019-11-21 | 2019-11-25 | 2,742,239 | — | $0 | 0 | SEC↗ |
| Kong Garheng | Director | D To issuer | 2019-11-21 | 2019-11-26 | 1,437,096 | — | $0 | 0 | SEC↗ |
| Rajpal Rajesh K. | Chief Medical Officer | M Exercise deriv | 2019-11-14 | 2019-11-18 | 3,321 | — | $0 | 5,535 | SEC↗ |
| Rajpal Rajesh K. | Chief Medical Officer | M Exercise deriv | 2019-11-14 | 2019-11-18 | 1,558 | — | $0 | 14,016 | SEC↗ |
| Rajpal Rajesh K. | Chief Medical Officer | M Exercise deriv | 2019-11-14 | 2019-11-18 | 4,221 | — | $0 | 4,222 | SEC↗ |
| Rajpal Rajesh K. | Chief Medical Officer | M Exercise deriv | 2019-11-14 | 2019-11-18 | 1,911 | — | $0 | 20,371 | SEC↗ |
| Rajpal Rajesh K. | Chief Medical Officer | M Exercise | 2019-11-14 | 2019-11-18 | 1,558 | $2.14 | $3.3K | 121,534 | SEC↗ |
| Rajpal Rajesh K. | Chief Medical Officer | M Exercise | 2019-11-14 | 2019-11-18 | 4,221 | $2.14 | $9.0K | 125,755 | SEC↗ |
| Rajpal Rajesh K. | Chief Medical Officer | M Exercise | 2019-11-14 | 2019-11-18 | 1,911 | $3.69 | $7.1K | 127,666 | SEC↗ |
| Rajpal Rajesh K. | Chief Medical Officer | M Exercise | 2019-11-14 | 2019-11-18 | 3,321 | $1.34 | $4.5K | 119,976 | SEC↗ |
| Bavier Paul S | General Counsel and Sec. | M Exercise deriv | 2019-09-03 | 2019-09-05 | 848 | — | $0 | 12,717 | SEC↗ |
| First David | Chief Human Resources Office | M Exercise deriv | 2019-09-03 | 2019-09-05 | 754 | — | $0 | 11,304 | SEC↗ |
| GRIFFIN THOMAS E | Chief Financial Officer | M Exercise deriv | 2019-09-03 | 2019-09-05 | 1,007 | — | $0 | 15,093 | SEC↗ |
| Rajpal Rajesh K. | Chief Medical Officer | M Exercise deriv | 2019-09-03 | 2019-09-05 | 107 | — | $0 | 212 | SEC↗ |
| Rajpal Rajesh K. | Chief Medical Officer | M Exercise deriv | 2019-09-03 | 2019-09-05 | 942 | — | $0 | 14,130 | SEC↗ |
| Schuermann James | Chief Business Officer | M Exercise deriv | 2019-09-03 | 2019-09-05 | 942 | — | $0 | 14,130 | SEC↗ |
| Zadno Reza | President and CEO | M Exercise deriv | 2019-09-03 | 2019-09-05 | 1,051 | — | $0 | 2,103 | SEC↗ |
| Zadno Reza | President and CEO | M Exercise deriv | 2019-09-03 | 2019-09-05 | 5,096 | — | $0 | 76,430 | SEC↗ |
| Bavier Paul S | General Counsel and Sec. | M Exercise | 2019-09-03 | 2019-09-05 | 848 | — | $0 | 848 | SEC↗ |
| Bavier Paul S | General Counsel and Sec. | F Tax w/h | 2019-09-03 | 2019-09-05 | 242 | $22.93 | $5.5K | 606 | SEC↗ |
| First David | Chief Human Resources Office | M Exercise | 2019-09-03 | 2019-09-05 | 754 | — | $0 | 2,254 | SEC↗ |
| GRIFFIN THOMAS E | Chief Financial Officer | M Exercise | 2019-09-03 | 2019-09-05 | 1,007 | — | $0 | 12,507 | SEC↗ |
| Rajpal Rajesh K. | Chief Medical Officer | M Exercise | 2019-09-03 | 2019-09-05 | 1,049 | — | $0 | 116,655 | SEC↗ |
| Schuermann James | Chief Business Officer | M Exercise | 2019-09-03 | 2019-09-05 | 942 | — | $0 | 942 | SEC↗ |
| Zadno Reza | President and CEO | M Exercise | 2019-09-03 | 2019-09-05 | 6,147 | — | $0 | 19,815 | SEC↗ |
| Zadno Reza | President and CEO | F Tax w/h | 2019-09-03 | 2019-09-05 | 1,753 | $22.93 | $40.2K | 18,062 | SEC↗ |
| Rajpal Rajesh K. | Chief Medical Officer | M Exercise deriv | 2019-08-07 | 2019-08-09 | 44,703 | — | $0 | 8,443 | SEC↗ |
| Rajpal Rajesh K. | Chief Medical Officer | M Exercise deriv | 2019-08-07 | 2019-08-09 | 9,343 | — | $0 | 15,574 | SEC↗ |
| Rajpal Rajesh K. | Chief Medical Officer | M Exercise deriv | 2019-08-07 | 2019-08-09 | 44,290 | — | $0 | 8,856 | SEC↗ |
| Rajpal Rajesh K. | Chief Medical Officer | M Exercise deriv | 2019-08-07 | 2019-08-09 | 367 | — | $0 | 49,071 | SEC↗ |
| Rajpal Rajesh K. | Chief Medical Officer | M Exercise deriv | 2019-08-07 | 2019-08-09 | 8,279 | — | $0 | 22,282 | SEC↗ |
| Rajpal Rajesh K. | Chief Medical Officer | M Exercise | 2019-08-07 | 2019-08-09 | 8,279 | $3.69 | $30.5K | 115,558 | SEC↗ |
| Rajpal Rajesh K. | Chief Medical Officer | M Exercise | 2019-08-07 | 2019-08-09 | 44,290 | $1.34 | $59.3K | 53,233 | SEC↗ |
| Rajpal Rajesh K. | Chief Medical Officer | M Exercise | 2019-08-07 | 2019-08-09 | 9,343 | $2.14 | $20.0K | 62,576 | SEC↗ |
| Rajpal Rajesh K. | Chief Medical Officer | M Exercise | 2019-08-07 | 2019-08-09 | 367 | $12.73 | $4.7K | 115,925 | SEC↗ |
| Rajpal Rajesh K. | Chief Medical Officer | M Exercise | 2019-08-07 | 2019-08-09 | 44,703 | $2.14 | $95.7K | 107,279 | SEC↗ |
| Bavier Paul S | General Counsel and Sec. | A Award deriv | 2019-06-14 | 2019-06-18 | 13,565 | — | $0 | 13,565 | SEC↗ |
| Burns Thomas William | Director | A Award deriv | 2019-06-14 | 2019-06-18 | 3,005 | — | $0 | 3,005 | SEC↗ |
| First David | Chief Human Resources Office | A Award deriv | 2019-06-14 | 2019-06-18 | 12,058 | — | $0 | 12,058 | SEC↗ |
| GRIFFIN THOMAS E | Chief Financial Officer | A Award deriv | 2019-06-14 | 2019-06-18 | 16,100 | — | $0 | 16,100 | SEC↗ |
| Kliman Gilbert H | Director, 10% Owner | A Award deriv | 2019-06-14 | 2019-06-18 | 3,005 | — | $0 | 3,005 | SEC↗ |
| Kong Garheng | Director | A Award deriv | 2019-06-14 | 2019-06-18 | 3,005 | — | $0 | 3,005 | SEC↗ |
| Lu Hongbo | Director | A Award deriv | 2019-06-14 | 2019-06-18 | 3,005 | — | $0 | 3,005 | SEC↗ |
| PALMISANO ROBERT J | Director | A Award deriv | 2019-06-14 | 2019-06-18 | 3,005 | — | $0 | 3,005 | SEC↗ |
| Rajpal Rajesh K. | Chief Medical Officer | A Award deriv | 2019-06-14 | 2019-06-18 | 15,072 | — | $0 | 15,072 | SEC↗ |
| Schuermann James | Chief Business Officer | A Award deriv | 2019-06-14 | 2019-06-18 | 15,072 | — | $0 | 15,072 | SEC↗ |
| SILVERSTEIN JONATHAN | Director, 10% Owner | A Award deriv | 2019-06-14 | 2019-06-18 | 3,005 | — | $0 | 3,005 | SEC↗ |
| Zadno Reza | President and CEO | A Award deriv | 2019-06-14 | 2019-06-18 | 81,526 | — | $0 | 81,526 | SEC↗ |
| Zurbay Donald | Director | A Award deriv | 2019-06-14 | 2019-06-18 | 3,005 | — | $0 | 3,005 | SEC↗ |
| Rajpal Rajesh K. | Chief Medical Officer | M Exercise deriv | 2019-06-03 | 2019-09-05 | 106 | — | $0 | 319 | SEC↗ |
| Zadno Reza | President and CEO | M Exercise deriv | 2019-06-03 | 2019-09-05 | 1,051 | — | $0 | 3,154 | SEC↗ |
| Rajpal Rajesh K. | Chief Medical Officer | M Exercise | 2019-06-03 | 2019-09-05 | 106 | — | $0 | 115,606 | SEC↗ |
| Zadno Reza | President and CEO | M Exercise | 2019-06-03 | 2019-09-05 | 1,051 | — | $0 | 13,668 | SEC↗ |
| GRIFFIN THOMAS E | Chief Financial Officer | M Exercise deriv | 2019-05-08 | 2019-05-15 | 10,000 | — | $0 | 109,832 | SEC↗ |
| GRIFFIN THOMAS E | Chief Financial Officer | M Exercise | 2019-05-08 | 2019-05-15 | 10,000 | $2.67 | $26.7K | 11,500 | SEC↗ |
| Rajpal Rajesh K. | Chief Medical Officer | M Exercise deriv | 2019-03-01 | 2019-09-05 | 106 | — | $0 | 425 | SEC↗ |
| Zadno Reza | President and CEO | M Exercise deriv | 2019-03-01 | 2019-09-05 | 1,052 | — | $0 | 4,205 | SEC↗ |
| Rajpal Rajesh K. | Chief Medical Officer | M Exercise | 2019-03-01 | 2019-09-05 | 106 | — | $0 | 115,500 | SEC↗ |
| Zadno Reza | President and CEO | M Exercise | 2019-03-01 | 2019-09-05 | 1,052 | — | $0 | 12,617 | SEC↗ |
| Bavier Paul S | General Counsel and Sec. | A Award deriv | 2019-02-19 | 2019-02-19 | 44,494 | — | $0 | 44,494 | SEC↗ |
| Burns Thomas William | Director | A Award deriv | 2019-02-19 | 2019-02-19 | 8,314 | — | $0 | 8,314 | SEC↗ |
| First David | Chief Human Resources Office | A Award deriv | 2019-02-19 | 2019-02-19 | 39,550 | — | $0 | 39,550 | SEC↗ |
| GRIFFIN THOMAS E | Chief Financial Officer | A Award deriv | 2019-02-19 | 2019-02-19 | 52,808 | — | $0 | 52,808 | SEC↗ |
| NASR KHALED | 10% Owner | C Conversion deriv | 2019-02-19 | 2019-02-19 | 171,318 | — | $0 | 0 | SEC↗ |
| NASR KHALED | 10% Owner | C Conversion deriv | 2019-02-19 | 2019-02-19 | 222,119 | — | $0 | 0 | SEC↗ |
| NASR KHALED | 10% Owner | C Conversion deriv | 2019-02-19 | 2019-02-19 | 2,247,190 | — | $0 | 0 | SEC↗ |
| Kliman Gilbert H | Director, 10% Owner | A Award deriv | 2019-02-19 | 2019-02-19 | 8,314 | — | $0 | 8,314 | SEC↗ |
| Kliman Gilbert H | Director, 10% Owner | C Conversion deriv | 2019-02-19 | 2019-02-19 | 171,318 | — | $0 | 0 | SEC↗ |
| Kliman Gilbert H | Director, 10% Owner | C Conversion deriv | 2019-02-19 | 2019-02-19 | 222,119 | — | $0 | 0 | SEC↗ |
| Kliman Gilbert H | Director, 10% Owner | C Conversion deriv | 2019-02-19 | 2019-02-19 | 2,247,190 | — | $0 | 0 | SEC↗ |
| Kong Garheng | Director | A Award deriv | 2019-02-19 | 2019-02-19 | 8,314 | — | $0 | 8,314 | SEC↗ |
| Kong Garheng | Director | C Conversion deriv | 2019-02-19 | 2019-02-19 | 535,369 | — | $0 | 0 | SEC↗ |
| Kong Garheng | Director | C Conversion deriv | 2019-02-19 | 2019-02-19 | 561,673 | — | $0 | 0 | SEC↗ |
| Kong Garheng | Director | C Conversion deriv | 2019-02-19 | 2019-02-19 | 87,663 | — | $0 | 0 | SEC↗ |
| Lu Hongbo | Director | A Award deriv | 2019-02-19 | 2019-02-19 | 8,314 | — | $0 | 8,314 | SEC↗ |
| OrbiMed Capital GP VI LLC | 10% Owner | C Conversion deriv | 2019-02-19 | 2019-02-19 | 3,370,786 | — | $0 | 0 | SEC↗ |
| OrbiMed Capital GP VI LLC | 10% Owner | C Conversion deriv | 2019-02-19 | 2019-02-19 | 383,746 | — | $0 | 0 | SEC↗ |
| OrbiMed Capital GP VI LLC | 10% Owner | C Conversion deriv | 2019-02-19 | 2019-02-19 | 333,178 | — | $0 | 0 | SEC↗ |
| PALMISANO ROBERT J | Director | C Conversion deriv | 2019-02-19 | 2019-02-19 | 9,322 | — | $0 | 0 | SEC↗ |
| PALMISANO ROBERT J | Director | A Award deriv | 2019-02-19 | 2019-02-19 | 8,314 | — | $0 | 8,314 | SEC↗ |
| PALMISANO ROBERT J | Director | C Conversion deriv | 2019-02-19 | 2019-02-19 | 1,310 | — | $0 | 0 | SEC↗ |
| PALMISANO ROBERT J | Director | C Conversion deriv | 2019-02-19 | 2019-02-19 | 21,414 | — | $0 | 0 | SEC↗ |
| Rajpal Rajesh K. | Chief Medical Officer | A Award deriv | 2019-02-19 | 2019-02-19 | 49,438 | — | $0 | 49,438 | SEC↗ |
| Rajpal Rajesh K. | Chief Medical Officer | C Conversion deriv | 2019-02-19 | 2019-02-19 | 1,284 | — | $0 | 0 | SEC↗ |
| Rajpal Rajesh K. | Chief Medical Officer | C Conversion deriv | 2019-02-19 | 2019-02-19 | 444 | — | $0 | 0 | SEC↗ |
| Rajpal Rajesh K. | Chief Medical Officer | C Conversion deriv | 2019-02-19 | 2019-02-19 | 3,620 | — | $0 | 0 | SEC↗ |
| Schuermann James | Chief Business Officer | A Award deriv | 2019-02-19 | 2019-02-19 | 49,438 | — | $0 | 49,438 | SEC↗ |
| SILVERSTEIN JONATHAN | Director, 10% Owner | A Award deriv | 2019-02-19 | 2019-02-19 | 8,314 | — | $0 | 8,314 | SEC↗ |
| SILVERSTEIN JONATHAN | Director, 10% Owner | C Conversion deriv | 2019-02-19 | 2019-02-19 | 3,370,786 | — | $0 | 0 | SEC↗ |
| SILVERSTEIN JONATHAN | Director, 10% Owner | C Conversion deriv | 2019-02-19 | 2019-02-19 | 383,746 | — | $0 | 0 | SEC↗ |
| SILVERSTEIN JONATHAN | Director, 10% Owner | C Conversion deriv | 2019-02-19 | 2019-02-19 | 333,178 | — | $0 | 0 | SEC↗ |
| Zadno Reza | President and CEO | A Award deriv | 2019-02-19 | 2019-02-19 | 267,415 | — | $0 | 267,415 | SEC↗ |
| Zurbay Donald | Director | A Award deriv | 2019-02-19 | 2019-02-19 | 8,314 | — | $0 | 8,314 | SEC↗ |
| First David | Chief Human Resources Office | P Buy | 2019-02-19 | 2019-02-19 | 1,500 | $14.00 | $21.0K | 1,500 | SEC↗ |
| GRIFFIN THOMAS E | Chief Financial Officer | P Buy | 2019-02-19 | 2019-02-19 | 1,500 | $14.00 | $21.0K | 1,500 | SEC↗ |
| NASR KHALED | 10% Owner | C Conversion | 2019-02-19 | 2019-02-19 | 2,247,190 | — | $0 | 2,348,802 | SEC↗ |
| NASR KHALED | 10% Owner | C Conversion | 2019-02-19 | 2019-02-19 | 171,318 | — | $0 | 2,742,239 | SEC↗ |
| NASR KHALED | 10% Owner | C Conversion | 2019-02-19 | 2019-02-19 | 222,119 | — | $0 | 2,570,921 | SEC↗ |
| Kliman Gilbert H | Director, 10% Owner | C Conversion | 2019-02-19 | 2019-02-19 | 222,119 | — | $0 | 2,570,921 | SEC↗ |
| Kliman Gilbert H | Director, 10% Owner | C Conversion | 2019-02-19 | 2019-02-19 | 2,247,190 | — | $0 | 2,348,802 | SEC↗ |
| Kliman Gilbert H | Director, 10% Owner | C Conversion | 2019-02-19 | 2019-02-19 | 171,318 | — | $0 | 2,742,239 | SEC↗ |
| Kliman Gilbert H | Director, 10% Owner | P Buy | 2019-02-19 | 2019-02-19 | 25,000 | $14.00 | $350.0K | 25,000 | SEC↗ |
| Kong Garheng | Director | C Conversion | 2019-02-19 | 2019-02-19 | 87,663 | — | $0 | 197,197 | SEC↗ |
| Kong Garheng | Director | P Buy | 2019-02-19 | 2019-02-19 | 142,857 | $14.00 | $2.00M | 1,437,096 | SEC↗ |
| Kong Garheng | Director | C Conversion | 2019-02-19 | 2019-02-19 | 561,673 | — | $0 | 758,870 | SEC↗ |
| Kong Garheng | Director | C Conversion | 2019-02-19 | 2019-02-19 | 535,369 | — | $0 | 1,294,239 | SEC↗ |
| OrbiMed Capital GP VI LLC | 10% Owner | C Conversion | 2019-02-19 | 2019-02-19 | 383,746 | — | $0 | 4,240,128 | SEC↗ |
| OrbiMed Capital GP VI LLC | 10% Owner | C Conversion | 2019-02-19 | 2019-02-19 | 3,370,786 | — | $0 | 3,523,204 | SEC↗ |
| OrbiMed Capital GP VI LLC | 10% Owner | C Conversion | 2019-02-19 | 2019-02-19 | 333,178 | — | $0 | 3,856,382 | SEC↗ |
| PALMISANO ROBERT J | Director | C Conversion | 2019-02-19 | 2019-02-19 | 21,414 | — | $0 | 37,733 | SEC↗ |
| PALMISANO ROBERT J | Director | C Conversion | 2019-02-19 | 2019-02-19 | 1,310 | — | $0 | 16,319 | SEC↗ |
| PALMISANO ROBERT J | Director | C Conversion | 2019-02-19 | 2019-02-19 | 9,322 | — | $0 | 15,009 | SEC↗ |
| Rajpal Rajesh K. | Chief Medical Officer | C Conversion | 2019-02-19 | 2019-02-19 | 3,620 | — | $0 | 7,215 | SEC↗ |
| Rajpal Rajesh K. | Chief Medical Officer | C Conversion | 2019-02-19 | 2019-02-19 | 1,284 | — | $0 | 8,943 | SEC↗ |
| Rajpal Rajesh K. | Chief Medical Officer | C Conversion | 2019-02-19 | 2019-02-19 | 444 | — | $0 | 7,659 | SEC↗ |
| SILVERSTEIN JONATHAN | Director, 10% Owner | C Conversion | 2019-02-19 | 2019-02-19 | 3,370,786 | — | $0 | 3,523,204 | SEC↗ |
| SILVERSTEIN JONATHAN | Director, 10% Owner | C Conversion | 2019-02-19 | 2019-02-19 | 383,746 | — | $0 | 4,240,128 | SEC↗ |
| SILVERSTEIN JONATHAN | Director, 10% Owner | C Conversion | 2019-02-19 | 2019-02-19 | 333,178 | — | $0 | 3,856,382 | SEC↗ |
| Zurbay Donald | Director | P Buy | 2019-02-19 | 2019-02-19 | 3,500 | $14.00 | $49.0K | 3,500 | SEC↗ |
| Rajpal Rajesh K. | Chief Medical Officer | A Award deriv | 2019-02-13 | 2019-09-05 | 1,700 | — | $0 | 1,700 | SEC↗ |
| Rajpal Rajesh K. | Chief Medical Officer | M Exercise deriv | 2019-02-13 | 2019-09-05 | 1,169 | — | $0 | 531 | SEC↗ |
| Zadno Reza | President and CEO | M Exercise deriv | 2019-02-13 | 2019-09-05 | 11,565 | — | $0 | 5,257 | SEC↗ |
| Zadno Reza | President and CEO | A Award deriv | 2019-02-13 | 2019-09-05 | 16,822 | — | $0 | 16,822 | SEC↗ |
| Rajpal Rajesh K. | Chief Medical Officer | M Exercise | 2019-02-13 | 2019-09-05 | 1,169 | — | $0 | 3,064 | SEC↗ |
| Zadno Reza | President and CEO | M Exercise | 2019-02-13 | 2019-09-05 | 11,565 | — | $0 | 11,565 | SEC↗ |
| Rajpal Rajesh K. | Chief Medical Officer | A Award | 2019-02-13 | 2019-02-15 | 1,700 | — | $0 | 3,595 | SEC↗ |
| Zadno Reza | President and CEO | A Award | 2019-02-13 | 2019-02-15 | 16,822 | — | $0 | 16,822 | SEC↗ |